ERIPOSA

Serial Number 85932021
606

Registration Progress

Application Filed
May 14, 2013
Under Examination
Jun 17, 2014
Approved for Publication
Apr 22, 2014
Published for Opposition
Apr 22, 2014
Registered

Trademark Image

ERIPOSA

Basic Information

Serial Number
85932021
Filing Date
May 14, 2013
Published for Opposition
April 22, 2014
Abandonment Date
January 19, 2015
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 19, 2015
Classes
005

Rights Holder

Ironwood Pharmaceuticals, Inc.

03
Address
301 Binney Street
Cambridge, MA 02142

Ownership History

Ironwood Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Ironwood Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Michael J. Bevilacqua

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description
Jan 20, 2015 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 19, 2015 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 17, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 22, 2014 PUBO A PUBLISHED FOR OPPOSITION
Apr 22, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 14, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 10, 2014 ALIE A ASSIGNED TO LIE
Mar 10, 2014 ALIE A ASSIGNED TO LIE
Feb 21, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 20, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 19, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2013 CNRT R NON-FINAL ACTION WRITTEN
Sep 6, 2013 GNRT F NON-FINAL ACTION E-MAILED
Sep 6, 2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 30, 2013 DOCK D ASSIGNED TO EXAMINER
May 23, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2013 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for use in the treatment of chronic constipation, irritable bowel syndrome, gastrointestinal motility disorders and other gastrointestinal disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005